Concord Biotech

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue270.48248.99329.78226.11320.21
Expenses157.29148.90198.86147.94186.92
EBITDA127.32114.12145.1091.59146.70
EBIT114.02100.58131.3878.41133.39
Profit Before Tax113.17100.08130.9178.17133.29
Net Profit84.4974.5597.2158.2498.70
Financial Ratios
Operating Profit Margin48.53%47.39%45.49%42.44%47.30%
Net Profit Margin32.21%30.96%30.48%26.99%31.82%
Earning Per Share (Diluted)8.087.139.295.579.43
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ